The Centers for Disease Control and Prevention last week issued a health advisory with information on the multistate outbreak of severe pulmonary disease associated with using e-cigarette products. The advisory provides background on e-cigarette products, as well as recommendations for clinicians, public health officials and the public based on currently available information. As of Aug. 27, health departments from 25 states have reported 215 possible cases of pulmonary illnesses from users of e-cigarette products, resulting in one death, and additional reports are under investigation.
 
Health and Human Services Secretary Alex Azar said the department is “using every tool we have to get to the bottom of this deeply concerning outbreak of illnesses in Americans who use e-cigarettes. More broadly, we will continue using every regulatory and enforcement power we have to stop the epidemic of youth e-cigarette use. This situation, and the rising tide of youth tobacco use, is a top public health priority for the Trump Administration and every leader at HHS.”

Related News Articles

Headline
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier…
Headline
Josh Neff, CEO of CommonSpirit Mercy Hospital, discusses a new cutting-edge communication platform that sends patient EKGs directly from the ambulance to the…
Headline
A JAMA study published yesterday found that more adults age 45-49 have been diagnosed with colorectal cancer, a finding that coincides with recommendations by…
Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…